Integrated in silico – in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and febuxostat

Xanthine oxidase (XO) has been well-recognized as a validated target for the treatment of hyperuricemia and gout. Currently, there are two drugs in clinical use that shut down XO overactivity, allopurinol and febuxostat; however, detrimental side effects restrict their applications. Propolis is a un...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghallab, Dina S., Shawky, Eman, Metwally, Ali M., Celik, Ismail, Ibrahim, Reham S., Mohyeldin, Mohamed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979054/
https://www.ncbi.nlm.nih.gov/pubmed/35425287
http://dx.doi.org/10.1039/d1ra08011c

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979054/
https://www.ncbi.nlm.nih.gov/pubmed/35425287
http://dx.doi.org/10.1039/d1ra08011c

Ejemplares similares